Memidis Pharma strengthens commitment to women’s well-being at ‘The Menopause’ conference
On Wednesday 28 May 2025, Memidis Pharma participated in the congress ‘De Overgang’ in Utrecht, organised by Bohn Stafleu van Loghum. This congress focused on improving care for women in menopause, a phase of life that is often accompanied by various physical and mental complaints.
During the congress, various aspects of the menopause were discussed, including hormonal fluctuations, sleep disorders, mood swings and heart complaints. Experts such as Dr. Femi Janse, Prof. Dr. Birit Broekman and cardiologist Janneke Wittekoek shared their insights and experiences with the healthcare professionals present.
Memidis Pharma presented its latest products and treatments at the congress, aimed at alleviating menopausal symptoms. The company emphasized the importance of non-hormonal therapies as alternatives to hormonal treatments.
The ‘De Overgang’ conference offered a valuable platform for knowledge sharing and collaboration between healthcare professionals and industry.
